The market for transseptal access systems is expected to reach a market value of US $ 2 billion with a CAGR of 9.4% by 2

Posted by Steve Sharma on June 28th, 2022

Transseptal Access Systems Market 2022

The global market  for transseptal access systems is  expected to see a  CAGR of 9.4% and reach $ 2 billion by the year 2031. Digital innovation is the watchword. As such, digital health unicorns are coming. The upward swing in digital is therefore expected to take the entire healthcare vertical by storm over the next 10 years. This would be the state of the health vertical in the short term.

According to the latest revised industry analysis from Persistence Market Research, the global transseptal access systems market was worth over  $ 771 million  in 2020 and is projected to increase at a  CAGR of 9.4%  over the forecast period (2021-2031 ).

The increase in the obese population, the increase in the elderly population with a higher risk of heart disease, and the rapid technological advances in transseptal access systems are key factors contributing to a significant increase in their sales. For example, the industry has seen the introduction of advanced technologies such as left atrial appendage occlusion therapy for patients at high risk of stroke due to non-valvular atrial fibrillation (AF). Such developments reduce morbidity and improve the quality of life, as well as increase the survival rate.

Get a Free Sample Copy of this Report @  https://www.persistencemarketresearch.com/samples/18703

The market players are following various marketing strategies such as increasing the sales force, increasing the distribution channel, product launches and acquisitions.

• In 2012, Cook Medical opened a distribution center in Baesweiler, Germany. This expansion has led to greater penetration into the European market.
• In 2016 Terumo signed an agreement with Abbott Laboratories to acquire Vado Steerable Sheath.

Company profiles:

• Teramo Corporation
• PLC Medtronic
• St. Jude Medical (Laboratori Abbott)
• Boston Scientific
• Biosense Webster, Inc. (Johnson & Johnson)
• Merito Medical Systems, Inc.
• Baylis Medical Company Inc.
• Pressure Products Medical Device Manufacturing LLC
• Cook Medical LLC
• Transseptal Solutions, Inc.

Request for methodology @  https://www.persistencemarketresearch.com/methodology/18703

Key points of the market study

• Based on the product, transseptal access sheaths are leading with a market share of over 86%.
• Atrial fibrillation ablation is estimated to dominate the market by application. This segment accounted for approximately 65% ​​of the market share, mainly due to the increased prevalence of atrial fibrillation.
• Hospitals dominate with a 49% market share. The incidence of atrial fibrillation-related cases is soaring, which has led to an increase in the adoption of these therapies by various hospitals.
• By region, North America will dominate the global transseptal access systems market with a value share of approximately 33%.
• Europe is expected to become the second largest market with a 25% value share during the forecast period.

“The launch of new product lines and continued improvements in available transseptal access systems have improved the safety and effectiveness of these systems,”  says a Persistence Market Research analyst.

Market competition

The launch of new products is the winning strategy used by leading manufacturers of transseptal access systems. Continuous technological advances and innovation in transseptal access systems are responsible for the intense competition between major players. Several organizations are focusing on approving new products and launching transseptal access systems.

• For example, in January 2019, Baylis Medical launched ExpanSure, a transseptal access system that combines dilators and sheaths in a single device, which aids in greater dilation than fixed curve sheaths.
• In 2018, Transseptal Solutions Ltd obtained US FDA approval for the TSP Crosser transseptal access system, which aims to provide consistent catheter placement and meticulous access.

What does the report cover?

Persistence Market Research offers a unique perspective and actionable insights into the transseptal access systems market in its latest study, presenting a historical demand assessment for 2016-2020 and projections for 2021-2031.

Access the full report @  https://www.persistencemarketresearch.com/checkout/18703

The research study is based on the product {Transsetal Access Needle (Standard Curve (C0) Needle and Large Curve (C1) Needle) and Transseptal Access Sheath (Steerable Sheath and Fixed Sheath)}, application (Atrial fibrillation ablation, valve repair mitral and left atrial appendix occlusion) and end users (hospitals, outpatient surgical centers and specialized clinics), in seven key regions of the world.

Who we are:

Persistence Market Research (PMR), as a third-party research organization, works through a unique fusion of market research and data analytics to help companies rise to the top, regardless of the turmoil faced due to financial / natural crises.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
US Ph. - + 1-646-568-7751
USA-Canada Toll Free - +1 800-961-0353
Sales  - sales @ persistencemarketresearch
Site web .com - https://www.persistencemarketresearch.com